Hobson AR, Furlong PL, Sarkar S, et al. Neurophysiologic assessment of esophageal sensory processing in non‐cardiac chest pain. Gastroenterology 2006; 130:80–88.
52 52 Rao SSC, Gregersen H, Hayek B, et al. Unexplained chest pain: the hypersensitive, hyperreactive, and poorly compliant esophagus. Ann Intern Med 1996; 124:950.
53 53 Balaban DH, Yamamoto Y, Liu J, et al. Sustained esophageal contraction: A marker of esophageal chest pain identified by intraluminal ultrasonography. Gastroenterology 1999; 116:29–37.
54 54 Pehlivanov N, Liu J, Mittal RK. Sustained esophageal contraction: a motor correlate of heartburn symptom. Am J Physiol Liver Physiol 2001; 281:G743–G751.
55 55 Bhalla V, Liu J, Puckett JL, et al. Symptom hypersensitivity to acid infusion is associated with hypersensitivity of esophageal contractility. Am J Physiol Liver Physiol 2004; 287:G65–G71.
56 56 McIntosh K, Paterson WG. Sustained esophageal longitudinal smooth muscle contraction may not be a cause of noncardiac chest pain. Neurogastroenterol Motil 2018; 30:1–6.
57 57 Yang M, Li Z, Chen D, et al. Quantitative assessment and characterization of visceral hyperalgesia evoked by esophageal balloon distention and acid perfusion in patients with functional heartburn, nonerosive reflux disease, and erosive esophagitis. Clin J Pain 2010; 26:326–331.
58 58 Holzer P. Acid‐sensing ion channels in gastrointestinal function. Neuropharmacology 2015; 94:72–79.
59 59 Holzer P. Acid sensing by visceral afferent neurones. Acta Physiol 2011; 201:63–75.
60 60 Galligan J. Actions of sumatriptan on myenteric neurones: relief from an old headache in the enteric nervous system? Neurogastroenterol Motil 2007; 19:1–3.
61 61 Yu S, Undem BJ, Kollarik M. Vagal afferent nerves with nociceptive properties in guinea‐pig oesophagus. J Physiol 2005; 563:831–842.
62 62 Barlow WJ, Orlando RC. The pathogenesis of heartburn in nonerosive reflux disease: A unifying hypothesis. Gastroenterology 2005; 128:771–778.
63 63 Tobey N, Hosseini S, Argote C, et al. Dilated intercellular spaces and shunt permeability in non‐erosive acid‐damaged esophageal epithelium. Am J Gastroenterol 2004; 99:13–22.
64 64 Tobey N. The role of pepsin in acid injury to esophageal epithelium. Am J Gastroenterol 2001; 96:3062–3070.
65 65 Zhang S, Owyang C, Liu Z, et al. Intraluminal acid activates esophageal nodose C fibers after mast cell activation. Am J Physiol Liver Physiol 2013; 306:G200–G207.
66 66 Groschwitz KR, Wu D, Osterfeld H, et al. Chymase‐mediated intestinal epithelial permeability is regulated by a protease‐activating receptor/matrix metalloproteinase‐2–dependent mechanism. Am J Physiol Liver Physiol 2013; 304:G479–G489.
67 67 Groschwitz KR, Ahrens R, Osterfeld H, et al. Mast cells regulate homeostatic intestinal epithelial migration and barrier function by a chymase/Mcpt4–dependent mechanism. Proc Natl Acad Sci 2009; 106:22381–22386.
68 68 Scudamore CL. Release of the mucosal mast cell granule chymase, rat mast cell protease‐II, during anaphylaxis is associated with the rapid development of paracellular permeability to macromolecules in rat jejunum. J Exp Med 1995; 182:1871–1881.
69 69 Snoek SA, Dhawan S, van Bree SH, et al. Mast cells trigger epithelial barrier dysfunction, bacterial translocation and postoperative ileus in a mouse model. Neurogastroenterol Motil 2012; 24:172–e91.
70 70 Souza RF, Huo X, Mittal V, et al. Gastroesophageal reflux might cause esophagitis through a cytokine‐mediated mechanism rather than caustic acid Injury. Gastroenterology 2009; 137:1776–1784.
71 71 Wu L, Oshima T, Shan J, et al. PAR‐2 activation enhances weak acid‐induced ATP release through TRPV1 and ASIC sensitization in human esophageal epithelial cells. Am J Physiol Liver Physiol 2015; 309:G695–G702.
72 72 Kondo T, Oshima T, Tomita T, et al. Prostaglandin E 2 mediates acid‐induced heartburn in healthy volunteers. Am J Physiol Liver Physiol 2013; 304:G568–G573.
73 73 Sei H, Oshima T, Shan J, et al. Correction: Esophageal epithelial‐derived IL‐33 Is upregulated in patients with heartburn. PLoS One 2016; 11:e0158932.
74 74 Yoshida N, Imamoto E, Uchiyama K, et al. Molecular mechanisms involved in interleukin‐8 production by normal human oesophageal epithelial cells. Aliment Pharmacol Ther 2006; 24:219–226.
75 75 Huo X, Souza RF. Acid burn or cytokine sizzle in the pathogenesis of heartburn? J Gastroenterol Hepatol 2013; 28:385–387.
76 76 Willert RP, Woolf CJ, Hobson AR, et al. The development and maintenance of human visceral pain hypersensitivity is dependent on the N‐methyl‐d‐aspartate receptor. Gastroenterology 2004; 126:683–692.
77 77 Willert RP, Delaney C, Kelly K, et al. Exploring the neurophysiological basis of chest wall allodynia induced by experimental oesophageal acidification ? evidence of central sensitization. Neurogastroenterol Motil 2007; 19:270–278.
78 78 Banerjee B, Medda BK, Zheng Y, et al. Alterations in N‐methyl‐d‐aspartate receptor subunits in primary sensory neurons following acid‐induced esophagitis in cats. Am J Physiol Liver Physiol 2009; 296:G66–G77.
79 79 Hubscher CH, Kaddumi EG, Johnson RD. Brain stem convergence of pelvic viscerosomatic inputs via spinal and vagal afferents. Neuroreport 2004; 15:1299–1302.
80 80 Farmer AD, Ruffle JK, Aziz Q. The role of esophageal hypersensitivity in functional esophageal disorders. J Clin Gastroenterol 2017; 51:91–99.
81 81 Giamberardino MA, Costantini R, Affaitati G, et al. Viscero‐visceral hyperalgesia: Characterization in different clinical models. Pain 2010; 151:307–322.
82 82 Fass R, Naliboff BD, Fass SS, et al. The effect of auditory stress on perception of intraesophageal acid in patients with gastroesophageal reflux disease. Gastroenterology 2008; 134:696–705.
83 83 Wright CE, Ebrecht M, Mitchell R, et al. The effect of psychological stress on symptom severity and perception in patients with gastro‐oesophageal reflux. J Psychosom Res 2005; 59:415–424.
84 84 Naliboff BD, Mayer M, Fass R, et al. The effect of life stress on symptoms of heartburn. Psychosom Med 2004; 66:426–434.
85 85 Guadagnoli L, Yadlapati RH, Taft T, et al. Esophageal hypervigilance and symptom anxiety are prevalent across gastroesophageal reflux disease phenotypes. Gastroenterology 2019; 156:S‐52.
86 86 Broers C, Melchior C, Van Oudenhove L, et al. The effect of intravenous corticotropin‐releasing hormone administration on esophageal sensitivity and motility in health. Am J Physiol Liver Physiol 2017; 312:G526–G534.
87 87 Vanuytsel T, van Wanrooy S, Vanheel H, et al. Psychological stress and corticotropin‐releasing hormone increase intestinal permeability in humans by a mast cell‐dependent mechanism. Gut 2014; 63:1293–1299.
88 88 Rodiño‐Janeiro BK, Alonso‐Cotoner C, Pigrau M, et al. Role of corticotropin‐releasing factor in gastrointestinal permeability. J Neurogastroenterol Motil 2015; 21:033–050.
89 89 Lee H, Kim JH, Min B‐H, et al. Efficacy of venlafaxine for symptomatic relief in young adult patients with functional chest pain: A randomized, double‐Bbind, placebo‐controlled, crossover trial. Am J Gastroenterol 2010; 105:1504–1512.
90 90 Doraiswamy PM, Varia I, Hellegers C, et al. A randomized controlled trial of paroxetine for non‐cardiac chest pain. Psychopharmacol Bull 2006; 39:15–24.
91 91 Broekaert D, Fischler B, Sifrim D, et al. Influence of citalopram, a selective serotonin reuptake inhibitor, on oesophageal hypersensitivity: a double‐blind, placebo‐controlled study. Aliment Pharmacol Ther 2006; 23:365–370.
92 92 Varia I, Logue E, O’Connor C, et al. Randomized trial of sertraline in patients with unexplained chest pain of noncardiac origin. Am Heart J 2000; 140:367–372.
93 93 Keefe FJ, Shelby RA, Somers TJ, et al. Effects of coping skills training and sertraline in patients with non‐cardiac chest pain: A randomized